APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medications for Chronic Pain Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medications for Chronic Pain Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchMedications for Chronic Pain Treatment Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Medications for Chronic Pain Treatment Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Medications for Chronic Pain Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medications for Chronic Pain Treatment Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Medications for Chronic Pain Treatment Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Medications for Chronic Pain Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medications for Chronic Pain Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medications for Chronic Pain Treatment include YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD., Southwest Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., REYOUNG, Johnson and Johnson Services Inc., Novartis AG, Merck & Co., Jiangsu Hengrui Medicine Co,.Ltd and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Medications for Chronic Pain Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medications for Chronic Pain Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medications for Chronic Pain Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Medications for Chronic Pain Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Medications for Chronic Pain Treatment Segment by Company

YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.

Southwest Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

REYOUNG

Johnson and Johnson Services Inc.

Novartis AG

Merck & Co.

Jiangsu Hengrui Medicine Co,.Ltd

Pfizer

GlaxoSmithKline plc.

BAYER

AstraZeneca plc.

Purdue Pharma L.P.

Endo International plc.

Depomed

Abbott Laboratories

Medications for Chronic Pain Treatment Segment by Type

Nonopioid

Opioids

Medications for Chronic Pain Treatment Segment by Application

Hospital

Pharmacy

Other

Medications for Chronic Pain Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medications for Chronic Pain Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medications for Chronic Pain Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medications for Chronic Pain Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Medications for Chronic Pain Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medications for Chronic Pain Treatment industry.

Chapter 3: Detailed analysis of Medications for Chronic Pain Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medications for Chronic Pain Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Nonopioid Table 3. Key Players of Opioids Table 4. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Pharmacy Table 7. Key Players of Other Table 8. Global Medications for Chronic Pain Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Medications for Chronic Pain Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Medications for Chronic Pain Treatment Market Share by Region (2021-2026) Table 11. Global Medications for Chronic Pain Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Medications for Chronic Pain Treatment Market Share by Region (2027-2032) Table 13. Medications for Chronic Pain Treatment Industry Trends Table 14. Medications for Chronic Pain Treatment Industry Drivers Table 15. Medications for Chronic Pain Treatment Industry Opportunities and Challenges Table 16. Medications for Chronic Pain Treatment Industry Restraints Table 17. Global Medications for Chronic Pain Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Medications for Chronic Pain Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Medications for Chronic Pain Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Medications for Chronic Pain Treatment Key Company Head Office and Area Served Table 21. Global Medications for Chronic Pain Treatment Company, Product Type & Application Table 22. Global Medications for Chronic Pain Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Medications for Chronic Pain Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Medications for Chronic Pain Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Medications for Chronic Pain Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Medications for Chronic Pain Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Medications for Chronic Pain Treatment Revenue Market Share by Application (2027-2032) Table 35. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Information Table 36. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview Table 37. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product Portfolio Table 39. YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Development Table 40. Southwest Pharmaceutical Co., Ltd. Company Information Table 41. Southwest Pharmaceutical Co., Ltd. Business Overview Table 42. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product Portfolio Table 44. Southwest Pharmaceutical Co., Ltd. Recent Development Table 45. Teva Pharmaceutical Industries Ltd. Company Information Table 46. Teva Pharmaceutical Industries Ltd. Business Overview Table 47. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product Portfolio Table 49. Teva Pharmaceutical Industries Ltd. Recent Development Table 50. REYOUNG Company Information Table 51. REYOUNG Business Overview Table 52. REYOUNG Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. REYOUNG Medications for Chronic Pain Treatment Product Portfolio Table 54. REYOUNG Recent Development Table 55. Johnson and Johnson Services Inc. Company Information Table 56. Johnson and Johnson Services Inc. Business Overview Table 57. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product Portfolio Table 59. Johnson and Johnson Services Inc. Recent Development Table 60. Novartis AG Company Information Table 61. Novartis AG Business Overview Table 62. Novartis AG Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Novartis AG Medications for Chronic Pain Treatment Product Portfolio Table 64. Novartis AG Recent Development Table 65. Merck & Co. Company Information Table 66. Merck & Co. Business Overview Table 67. Merck & Co. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Merck & Co. Medications for Chronic Pain Treatment Product Portfolio Table 69. Merck & Co. Recent Development Table 70. Jiangsu Hengrui Medicine Co,.Ltd Company Information Table 71. Jiangsu Hengrui Medicine Co,.Ltd Business Overview Table 72. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product Portfolio Table 74. Jiangsu Hengrui Medicine Co,.Ltd Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Pfizer Medications for Chronic Pain Treatment Product Portfolio Table 79. Pfizer Recent Development Table 80. GlaxoSmithKline plc. Company Information Table 81. GlaxoSmithKline plc. Business Overview Table 82. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product Portfolio Table 84. GlaxoSmithKline plc. Recent Development Table 85. BAYER Company Information Table 86. BAYER Business Overview Table 87. BAYER Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. BAYER Medications for Chronic Pain Treatment Product Portfolio Table 89. BAYER Recent Development Table 90. AstraZeneca plc. Company Information Table 91. AstraZeneca plc. Business Overview Table 92. AstraZeneca plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. AstraZeneca plc. Medications for Chronic Pain Treatment Product Portfolio Table 94. AstraZeneca plc. Recent Development Table 95. Purdue Pharma L.P. Company Information Table 96. Purdue Pharma L.P. Business Overview Table 97. Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Purdue Pharma L.P. Medications for Chronic Pain Treatment Product Portfolio Table 99. Purdue Pharma L.P. Recent Development Table 100. Endo International plc. Company Information Table 101. Endo International plc. Business Overview Table 102. Endo International plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Endo International plc. Medications for Chronic Pain Treatment Product Portfolio Table 104. Endo International plc. Recent Development Table 105. Depomed Company Information Table 106. Depomed Business Overview Table 107. Depomed Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Depomed Medications for Chronic Pain Treatment Product Portfolio Table 109. Depomed Recent Development Table 110. Abbott Laboratories Company Information Table 111. Abbott Laboratories Business Overview Table 112. Abbott Laboratories Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Abbott Laboratories Medications for Chronic Pain Treatment Product Portfolio Table 114. Abbott Laboratories Recent Development Table 115. North America Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 116. North America Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 117. North America Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 118. North America Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 119. North America Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Medications for Chronic Pain Treatment Market Size by Country (2021-2026) Table 121. North America Medications for Chronic Pain Treatment Market Size by Country (2027-2032) Table 122. Europe Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 123. Europe Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 124. Europe Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 125. Europe Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 126. Europe Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Medications for Chronic Pain Treatment Market Size by Country (2021-2026) Table 128. Europe Medications for Chronic Pain Treatment Market Size by Country (2027-2032) Table 129. China Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 130. China Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 131. China Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 132. China Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Asia Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Asia Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Asia Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Asia Medications for Chronic Pain Treatment Market Size by Country (2021-2026) Table 139. Asia Medications for Chronic Pain Treatment Market Size by Country (2027-2032) Table 140. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021-2026) Table 146. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2027-2032) Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Medications for Chronic Pain Treatment Product Image Figure 2. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Medications for Chronic Pain Treatment Market Share by Type: 2025 VS 2032 Figure 4. Nonopioid Image Figure 5. Opioids Image Figure 6. Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Medications for Chronic Pain Treatment Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Medications for Chronic Pain Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 13. Global Medications for Chronic Pain Treatment Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Medications for Chronic Pain Treatment Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Medications for Chronic Pain Treatment Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Medications for Chronic Pain Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Medications for Chronic Pain Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Medications for Chronic Pain Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medications for Chronic Pain Treatment Revenue Market Share by Application (2021-2032) Figure 22. North America Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 23. North America Medications for Chronic Pain Treatment Market Share by Type (2021-2032) Figure 24. North America Medications for Chronic Pain Treatment Market Share by Application (2021-2032) Figure 25. North America Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 26. United States Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 27. Canada Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Europe Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Medications for Chronic Pain Treatment Market Share by Type (2021-2032) Figure 31. Europe Medications for Chronic Pain Treatment Market Share by Application (2021-2032) Figure 32. Europe Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 33. Germany Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 34. France Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 36. Italy Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Russia Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 39. China Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Medications for Chronic Pain Treatment Market Share by Type (2021-2032) Figure 41. China Medications for Chronic Pain Treatment Market Share by Application (2021-2032) Figure 42. Asia Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 43. Asia Medications for Chronic Pain Treatment Market Share by Type (2021-2032) Figure 44. Asia Medications for Chronic Pain Treatment Market Share by Application (2021-2032) Figure 45. Asia Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 46. Japan Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 50. India Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Australia Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country (2021-2032) Figure 56. Brazil Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 61. UAE Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Chile Medications for Chronic Pain Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Nonopioid
  • Opioids
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
  • Southwest Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • REYOUNG
  • Johnson and Johnson Services Inc.
  • Novartis AG
  • Merck & Co.
  • Jiangsu Hengrui Medicine Co,.Ltd
  • Pfizer
  • GlaxoSmithKline plc.
  • BAYER
  • AstraZeneca plc.
  • Purdue Pharma L.P.
  • Endo International plc.
  • Depomed
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Medications for Chronic Pain Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Nonopioid
  5. 1.2.3 Opioids
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Medications for Chronic Pain Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Medications for Chronic Pain Treatment Growth Trends by Region
  13. 1.5.1 Global Medications for Chronic Pain Treatment Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Medications for Chronic Pain Treatment Market Size by Region (2021-2026)
  15. 1.5.3 Medications for Chronic Pain Treatment Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Medications for Chronic Pain Treatment Market Dynamics
  1. 2.1 Medications for Chronic Pain Treatment Industry Trends
  2. 2.2 Medications for Chronic Pain Treatment Industry Drivers
  3. 2.3 Medications for Chronic Pain Treatment Industry Opportunities and Challenges
  4. 2.4 Medications for Chronic Pain Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Medications for Chronic Pain Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Medications for Chronic Pain Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Medications for Chronic Pain Treatment Key Company Head office and Area Served
  4. 3.4 Global Medications for Chronic Pain Treatment Company, Product Type & Application
  5. 3.5 Global Medications for Chronic Pain Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Medications for Chronic Pain Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Medications for Chronic Pain Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Medications for Chronic Pain Treatment Tier 1, Tier 2, and Tier 3
4 Medications for Chronic Pain Treatment Market by Type
  1. 4.1 Global Medications for Chronic Pain Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Medications for Chronic Pain Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Medications for Chronic Pain Treatment Market Size Share by Type (2021-2032)
5 Medications for Chronic Pain Treatment Market by Application
  1. 5.1 Global Medications for Chronic Pain Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Medications for Chronic Pain Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Medications for Chronic Pain Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD.
  2. 6.1.1 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Company Information
  3. 6.1.2 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Business Overview
  4. 6.1.3 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Medications for Chronic Pain Treatment Product Portfolio
  6. 6.1.5 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO., LTD. Recent Developments
  7. 6.2 Southwest Pharmaceutical Co., Ltd.
  8. 6.2.1 Southwest Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Southwest Pharmaceutical Co., Ltd. Medications for Chronic Pain Treatment Product Portfolio
  12. 6.2.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Teva Pharmaceutical Industries Ltd.
  14. 6.3.1 Teva Pharmaceutical Industries Ltd. Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Ltd. Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Ltd. Medications for Chronic Pain Treatment Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  19. 6.4 REYOUNG
  20. 6.4.1 REYOUNG Company Information
  21. 6.4.2 REYOUNG Business Overview
  22. 6.4.3 REYOUNG Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 REYOUNG Medications for Chronic Pain Treatment Product Portfolio
  24. 6.4.5 REYOUNG Recent Developments
  25. 6.5 Johnson and Johnson Services Inc.
  26. 6.5.1 Johnson and Johnson Services Inc. Company Information
  27. 6.5.2 Johnson and Johnson Services Inc. Business Overview
  28. 6.5.3 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Johnson and Johnson Services Inc. Medications for Chronic Pain Treatment Product Portfolio
  30. 6.5.5 Johnson and Johnson Services Inc. Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis AG Medications for Chronic Pain Treatment Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Merck & Co.
  38. 6.7.1 Merck & Co. Company Information
  39. 6.7.2 Merck & Co. Business Overview
  40. 6.7.3 Merck & Co. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck & Co. Medications for Chronic Pain Treatment Product Portfolio
  42. 6.7.5 Merck & Co. Recent Developments
  43. 6.8 Jiangsu Hengrui Medicine Co,.Ltd
  44. 6.8.1 Jiangsu Hengrui Medicine Co,.Ltd Company Information
  45. 6.8.2 Jiangsu Hengrui Medicine Co,.Ltd Business Overview
  46. 6.8.3 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Jiangsu Hengrui Medicine Co,.Ltd Medications for Chronic Pain Treatment Product Portfolio
  48. 6.8.5 Jiangsu Hengrui Medicine Co,.Ltd Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Medications for Chronic Pain Treatment Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 GlaxoSmithKline plc.
  56. 6.10.1 GlaxoSmithKline plc. Company Information
  57. 6.10.2 GlaxoSmithKline plc. Business Overview
  58. 6.10.3 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GlaxoSmithKline plc. Medications for Chronic Pain Treatment Product Portfolio
  60. 6.10.5 GlaxoSmithKline plc. Recent Developments
  61. 6.11 BAYER
  62. 6.11.1 BAYER Company Information
  63. 6.11.2 BAYER Business Overview
  64. 6.11.3 BAYER Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 BAYER Medications for Chronic Pain Treatment Product Portfolio
  66. 6.11.5 BAYER Recent Developments
  67. 6.12 AstraZeneca plc.
  68. 6.12.1 AstraZeneca plc. Company Information
  69. 6.12.2 AstraZeneca plc. Business Overview
  70. 6.12.3 AstraZeneca plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AstraZeneca plc. Medications for Chronic Pain Treatment Product Portfolio
  72. 6.12.5 AstraZeneca plc. Recent Developments
  73. 6.13 Purdue Pharma L.P.
  74. 6.13.1 Purdue Pharma L.P. Company Information
  75. 6.13.2 Purdue Pharma L.P. Business Overview
  76. 6.13.3 Purdue Pharma L.P. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Purdue Pharma L.P. Medications for Chronic Pain Treatment Product Portfolio
  78. 6.13.5 Purdue Pharma L.P. Recent Developments
  79. 6.14 Endo International plc.
  80. 6.14.1 Endo International plc. Company Information
  81. 6.14.2 Endo International plc. Business Overview
  82. 6.14.3 Endo International plc. Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Endo International plc. Medications for Chronic Pain Treatment Product Portfolio
  84. 6.14.5 Endo International plc. Recent Developments
  85. 6.15 Depomed
  86. 6.15.1 Depomed Company Information
  87. 6.15.2 Depomed Business Overview
  88. 6.15.3 Depomed Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Depomed Medications for Chronic Pain Treatment Product Portfolio
  90. 6.15.5 Depomed Recent Developments
  91. 6.16 Abbott Laboratories
  92. 6.16.1 Abbott Laboratories Company Information
  93. 6.16.2 Abbott Laboratories Business Overview
  94. 6.16.3 Abbott Laboratories Medications for Chronic Pain Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Abbott Laboratories Medications for Chronic Pain Treatment Product Portfolio
  96. 6.16.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Medications for Chronic Pain Treatment Market Size (2021-2032)
  2. 7.2 North America Medications for Chronic Pain Treatment Market Size by Type
  3. 7.2.1 North America Medications for Chronic Pain Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Medications for Chronic Pain Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Medications for Chronic Pain Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Medications for Chronic Pain Treatment Market Size by Application
  7. 7.3.1 North America Medications for Chronic Pain Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Medications for Chronic Pain Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Medications for Chronic Pain Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Medications for Chronic Pain Treatment Market Size by Country
  11. 7.4.1 North America Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Medications for Chronic Pain Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Medications for Chronic Pain Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Medications for Chronic Pain Treatment Market Size (2021-2032)
  2. 8.2 Europe Medications for Chronic Pain Treatment Market Size by Type
  3. 8.2.1 Europe Medications for Chronic Pain Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Medications for Chronic Pain Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Medications for Chronic Pain Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Medications for Chronic Pain Treatment Market Size by Application
  7. 8.3.1 Europe Medications for Chronic Pain Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Medications for Chronic Pain Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Medications for Chronic Pain Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Medications for Chronic Pain Treatment Market Size by Country
  11. 8.4.1 Europe Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Medications for Chronic Pain Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Medications for Chronic Pain Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Medications for Chronic Pain Treatment Market Size (2021-2032)
  2. 9.2 China Medications for Chronic Pain Treatment Market Size by Type
  3. 9.2.1 China Medications for Chronic Pain Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Medications for Chronic Pain Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Medications for Chronic Pain Treatment Market Share by Type (2021-2032)
  6. 9.3 China Medications for Chronic Pain Treatment Market Size by Application
  7. 9.3.1 China Medications for Chronic Pain Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Medications for Chronic Pain Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Medications for Chronic Pain Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Medications for Chronic Pain Treatment Market Size (2021-2032)
  2. 10.2 Asia Medications for Chronic Pain Treatment Market Size by Type
  3. 10.2.1 Asia Medications for Chronic Pain Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Medications for Chronic Pain Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Medications for Chronic Pain Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Medications for Chronic Pain Treatment Market Size by Application
  7. 10.3.1 Asia Medications for Chronic Pain Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Medications for Chronic Pain Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Medications for Chronic Pain Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Medications for Chronic Pain Treatment Market Size by Country
  11. 10.4.1 Asia Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Medications for Chronic Pain Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Medications for Chronic Pain Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Medications for Chronic Pain Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst